Background {#Sec1}
==========

Ventricular tachycardia (VT) ablation is now frequently performed, with the rate of use of these procedures increasing substantially in the last decade \[[@CR1]\]. Recurrence of VT after a single ablation procedure remains high, with 35% of patients who receive initially successful ablation treatment later experiencing VT recurrence during 6--23 month follow-up periods \[[@CR2]\]. VT recurrence after an ablation procedure is complex and may be related to the inability to localize the critical circuit, or, when the circuit is defined, inability to obliterate the critical channels \[[@CR3]\]. Once the critical isthmus of a VT circuit is isolated, radiofrequency (RF) ablation is performed with the hope of creating a necrotic lesion (permanent injury) at the putative isthmus, rendering VT non-inducible. The insult of ablation also leads to edema (reversible injury) surrounding the ablation site \[[@CR4]--[@CR8]\]. This reversible injury is thought to result in transient conduction block, with conduction recovering once the edema has resorbed \[[@CR9]--[@CR11]\], potentially leading to late arrhythmia recurrence. The ability to detect whether the arrhythmogenic substrate has been permanently destroyed, as evidenced by the presence of a lesion at a critical ablation site, may be invaluable and provide an additional intra-procedural endpoint to gauge long-term procedural success.

Cardiovascular magnetic resonance (CMR)-based identification of the critical isthmus sites may be used to guide ablation toward these targets \[[@CR12]\], and the therapeutic lesions themselves can be directly visualized using native (non-contrast enhanced) CMR \[[@CR4]--[@CR8], [@CR10], [@CR13]--[@CR16]\].

Ablation lesions visualized using native T~1~ reflect injury that is associated with lethal heating \[[@CR17]\], that persists at least for 3 weeks \[[@CR13]\], and that correlates to chronic lesions \[[@CR6]\], therefore likely represents permanent injury. Conversely, myocardial edema is visualized with native T~2~ \[[@CR18]\] and is transient, largely resolved within 3 months as seen in follow-up T~2~-weighted imaging after atrial ablation \[[@CR8]\]. The T~1~-derived lesion and T~2~-derived edema are individually significant in clinical ablations as the distributions of these injured regions could determine whether electrical block will remain permanently or resolve after healing (leading to recurrent VT). To evaluate these regions, this study includes concurrent native T~1~- and T~2~-based imaging to compare their relative extents and to construct a comprehensive understanding of the acute lesion composition.

A major potential value of intra-procedural CMR imaging lies in the ability to directly visualize and interpret the functional effect of therapeutic ablation lesions during the period when intra-procedural modification is possible. It is therefore important to identify how different aspects of CMR information evolve in this time window and how this information might be related to conventional electrophysiology (EP) endpoints. This study aims to characterize the evolution of lesions, as previously suggested to take place \[[@CR16]\], but using concurrent imaging of both the T~2~-derived edema and T~1~-derived lesion to provide volumetric measurements of each. We hypothesize that the acute ablation-induced T~2~-derived edema evolves during the acute time frame while the T~1~-derived lesion remains at a consistent size. Furthermore, adding T~2~ mapping to this imaging framework provides unambiguous quantification of edema severity. These techniques to study the acute lesion composition build upon prior work studying lesion characteristics via the surrogate measure of gadolinium kinetics \[[@CR19]\]. This study aims to show temporal characteristics of the native T~1~-derived lesion and T~2~-derived edema within a time frame of particular relevance to direct CMR guidance of ablative therapies, extending the current understanding of lesion evolution previously established using native-contrast CMR \[[@CR5]\] to an earlier time frame. Insights from lesion evolution could be applied to both CMR-guided and traditional ablation cases.

Methods {#Sec2}
=======

Animal preparation {#Sec3}
------------------

CMR-guided RF ablation was performed in vivo in 12 healthy Yorkshire swine (58 ± 18 kg). The Animal Care Committee of Sunnybrook Research Institute approved all protocols. All animals received an intramuscular injection of ketamine (33 mg/kg) and atropine (0.05 mg/kg) pre-anaesthesia, followed by isoflurane gas (1--5%) continuously delivered via mechanical ventilation to maintain the surgical stage of anaesthesia. A sheath in one carotid artery acted as a port for catheter introduction. To mitigate arrhythmia, a bolus of amiodarone (75 mg) was given prior to the intervention, in addition to lidocaine (20 mg) as needed.

CMR-guided intervention {#Sec4}
-----------------------

The entire intervention was performed within a 1.5 T wide-bore scanner (MR450w, General Electric Healthcare Waukesha, Wisconsin, USA). Figure [1](#Fig1){ref-type="fig"} illustrates the interventional workflow and timing of data collection throughout. A 4-channel anterior cardiac array coil was used for all imaging, and was connected to the scanner bed separately from the catheter tip tracking coils. The CMR-enabled EP hardware configuration has been described previously \[[@CR20]\].Fig. 1CMR-guided intervention experimental workflow. **a** Data acquisition and repeated lesion imaging performed throughout CMR-guided interventions. **b** Still frame of the actively-tracked catheter tip (blue and red arrow) during navigation overlaid on anatomical roadmap images in VURTIGO \[[@CR22]\]. The LV endocardial surface (pink shell) was automatically delineated \[[@CR41]\] and displayed to assist navigation. **c** Bipolar intracardiac electrogram (EGM) traces recorded from the catheter held at the ablation site immediately before ablation (upper panel) and approximately 3 s after stopping RF delivery (lower panel). **d** Anterior wall RF lesion visualized in T~2~-weighted images. Each stack of T~2~-weighted images was acquired at 4 TEs to construct T~2~ maps (16 s breath-holds, approximately 4 ± 2 min in duration), which were reconstructed offline, along with all image analysis. **e** RF lesion visualized in T~1~-weighted IR-SSFP. IR-SSFP images were acquired in a stack of several 2D images with each slice requiring 1 breath-hold 16 s long. Scale bars = 1 cm

Pre-procedure scans included short- and long-axis stacks of 2D balanced steady-state free-precession (bSSFP; CINE) images to serve as anatomical roadmaps (20 cardiac phases across 1 R-R interval, TR/TE = 5.2/1.9 ms, resolution = 1.25 × 1.5 mm, slice thickness = 6 mm). Both orientations were acquired at a rate of 1 breath-hold (approximately 14 s) per slice over 8 ± 3 min in total.

A 9 F CMR-enabled catheter (Imricor Medical Systems, Burnsville, Minnesota, USA) equipped with 2 micro-receive coils and 2 electrodes (3.7-mm tip electrode and 3.5-mm inter-electrode spacing) was used for the entire intervention. Active catheter tracking using a projection sequence \[[@CR21]\] (FOV = 60 cm, flip angle = 5°, TR = 14.3 ms, tracking rate = 23 fps) was implemented in RTHawk software (HeartVista Inc., Menlo Park, California, USA). The catheter tip position was updated in real time and visualized overlaid on static anatomical roadmap images (Fig. [1b](#Fig1){ref-type="fig"}) simultaneously in VURTIGO, 4D visualization software for cardiovascular interventional guidance (Sunnybrook Research Institute, Toronto, Ontario, Canada) \[[@CR22]\]. Bipolar intracardiac electrogram (EGM; Fig. [1c](#Fig1){ref-type="fig"}) traces from the catheter tip's electrodes were recorded by the Advantage-MR system (Imricor Medical Systems). EP traces and VURTIGO catheter navigation visualization were displayed on monitors in the CMR control room and on CMR-compatible monitors near the scanner bed to assist the interventionalist. Once the catheter was inserted into the heart to access the LV via the aortic valve, ablations were delivered from the catheter's distal electrode (1500 T14 generator, St Jude Medical, St. Paul, Minnesota, USA) with 17 mL/min irrigation and with the dispersive electrode placed on the animal's back. Ablations were delivered endocardially, in accordance with the more common clinical ablation approach (details given in Table [1](#Tab1){ref-type="table"}). Conservative ablation parameters were chosen to avoid inducing arrhythmia during ablation. Ablation was generally performed in similar locations for consistency, but targeting accuracy was not directly evaluated as no specific targeting was used for lesion placement. Vital signs including electrocardiogram (ECG), end-tidal CO~2~, and peripheral capillary oxygen saturation were monitored using the Expression CMR Patient Monitor (Invivo Corp., Gainesville, Florida, USA). Peripheral pulse sensing from each animal's foot was sufficient for robust cardiac gating, and respiratory motion was frozen during imaging by pausing mechanical ventilation.Table 1Summary of ablation details and imaging dataLesion \#LocationRF power / DurationT~2~ map time span \[min\]IR-SSFP time span \[min\]MCLEGross pathology lesion diameter \[mm\]Subject mode of death1Anterolateral wall30 W/60 s40--60\*+8.0Arrhythmia2Anteroseptal wall30 W/60 s19--56\*+6.8Euthanasia3Anterior wall30 W/60 s13--7324--81+10.1Euthanasia4Anterolateral wall30 W/60 s8--68\*+10.3Euthanasia5Anterior wall30 W/90 sNot used due to artifact33--55--11.8Arrhythmia6Anteroseptal wall, apical30 W/90 s10--22436--246+8.1Arrhythmia7Anterolateral wall, apical30 W/70 s8--64\*+9.1Arrhythmia8Anterior wall30 W/100 s3--17220--184--11.9Arrhythmia9Anterior wall30 W/120 s11--71\*--4.3Arrhythmia10Anterior wall35 W/120 s11--12718--132--7.9Arrhythmia11Anterior wall35 W/120 s6--10923--114+8.7Euthanasia12Anterior wall35 W/120 s6--9815--107+12.1Arrhythmia13Anterior wall30 W/90 s9--17119--184+7.1Euthanasia14Anteroseptal wall35 W/120 s21--25013--245+7.4EuthanasiaAbbreviations: *IR-SSFP* inversion recovery balanced steady-state free precession, *MCLE* multi-contrast late enhancement, *RF* radiofrequencyT~2~ map and IR-SSFP time spans indicate the first and last acquisitions of each type (\* = lesion not clearly apparent, likely due to partial-volume effects, +/− = acquired/not acquired). Lesions 3 and 4 were created in the same individual, likewise for lesions 6 and 7

CMR imaging protocol {#Sec5}
--------------------

Imaging began immediately after catheter withdrawal (as early as 3 min after the start of ablation) to visualize the lesion near the catheter contact point. The two primary native contrast (non-contrast enhanced) imaging sequences used were alternated regularly at consistent slice locations to evaluate RF lesion temporal evolution.

T~2~ mapping was performed using a previously validated T~2~-prepared spiral sequence to detect regional T~2~ changes near the ablation site reflecting inflamed edematous tissue (4 TEs between 3 and 184 ms, TR = 2 R-R intervals, 10 interleaves, 3072 points, FOV = 240 mm, readout bandwidth = 125 kHz, effective resolution = 1.3 × 1.3 mm, slice thickness = 6 mm). Images at one TE were acquired per breath-hold (approximately 16 s), and complete maps were acquired in 4 ± 2 min.

An IR-SSFP sequence generated images with various inversion times at 40 cardiac phases across 2 R-R intervals \[[@CR23]\]. Typical acquisition parameters were: views/segment = 16, flip angle = 45°, TR/TE = 5.6/2.0 ms, readout bandwidth = 62.5 kHz, FOV = 240 mm, matrix = 192 × 160, and slice thickness = 6 mm. Although SSFP sequences yield best quality with shorter TRs (e.g., TR = 2.7--4 ms at 1.5 T \[[@CR7], [@CR23]\]), this TR was longer than ideal in this wide-bore system with lower gradient specifications. This was the shortest achievable TR while maintaining other sequence parameters. Local shimming was performed to mitigate any off-resonance effects, and dark-band artifacts were not observed in the regions of interest.

RF ablation lesions were hyper-enhanced in IR-SSFP images due to shorter T~1~ compared to the healthy myocardium \[[@CR7], [@CR24]\]. TIs longer than approximately 700 ms (yielding optimal contrast for lesion core visualization \[[@CR7], [@CR13], [@CR25]\]) were set to occur within diastole. Image acquisition was performed at 1 slice per breath-hold (each approximately 16 s), such that 5 slices with 2 rest breaths between each slice could be acquired within 2 min. Sequence parameters were adjusted slightly to accommodate animal size and heart rate (typically 75--95 bpm).

Native-contrast imaging was repeated up to approximately 3 h post-ablation. At the end of the CMR study a bolus of Gd-DTPA (0.2 mmol/kg, Magnevist, Bayer Healthcare Pharmaceuticals, Berlin, Germany) was injected for contrast-enhanced imaging to confirm the pattern of ablation. The IR-SSFP sequence was repeated after contrast agent injection (referred to as MCLE \[[@CR23]\]), acquired at 1 slice per breath-hold, at 6 ± 5 min post-injection. Four of 12 animals succumbed to arrhythmia before the end of the imaging study when MCLE images were to be acquired. Animals were not moved during the CMR study; therefore, all images were well aligned post-ablation (confirmed via anatomical landmarks in corresponding images).

*Ex vivo* examination {#Sec6}
---------------------

After the imaging study (within hours of ablation), animals were euthanized and the hearts explanted immediately, then preserved in a 10% formalin solution. Hearts were embedded in dental alginate gel and sliced to 4-mm blocks aligned to the imaging plane for gross examination and measurement of lesion dimensions. Tissue blocks were sliced to 4-μm sections and stained with Hematoxylin and Eosin (H&E) and Masson's trichrome (MT) to emphasize tissue morphological changes and viability, respectively. Slides were scanned under light microscopy (Leica SCN400 F, Leica Microsystems, Wetzlar, Germany) at 20× magnification (0.5 μm resolution) to observe features of healthy tissue, the lesion, and peripheral regions around the ablation site. Edema extent was not assessed *ex vivo* given the challenge of determining associated borders in tissue sections. CMR images were taken as a more accurate representation of the extent of edema in vivo. Observations from histopathology were qualitative in support of the image-based observations of ablation injury patterns.

Data analysis & statistics {#Sec7}
--------------------------

All analysis was performed offline in MATLAB (MathWorks, Inc., Natick, Massachusetts, USA). Images were interpolated to a 256 × 256 matrix (DICOM format) before processing. T~2~ maps were generated using a previously-validated 3-parameter model \[[@CR26]\] (approximately 15 s per map using non-optimized code). Regions of edematous tissue exhibiting increased T~2~ were segmented semi-automatically by applying a threshold of 3 standard deviations (SDs) above mean T~2~ in healthy tissue (similarly to the approach used in a prior ablation study \[[@CR27]\]). Morphological operations were applied to this mask to remove noise and other erroneous pixels (MATLAB Image Processing Toolbox), identify edema as contiguous regions of segmented pixels, and fill these regions while preserving borders. This semi-automatic approach was implemented to yield reproducible volumes despite the often-diffuse quality of edema, and could be performed within approximately 2 min per slice.

IR-SSFP images acquired at TIs longer than approximately 700 ms were selected for lesion segmentation, with matching contrast in subsequent acquisitions. The T~1~-derived lesion volumes were segmented semi-automatically using a threshold of 2 SD above adjacent healthy myocardial signal intensity (SI), and correlated well with an expert viewer's manual delineation of lesion volumes (Pearson's *r* = 0.95, intercept = − 0.078, slope = 1.2, *p* \< \< 0.0001; 2 SD segmented volumes larger by 0.0017 ± 0.10 mL overall; 95% limits of agreement \[− 0.030, 0.033\]). Segmentation required approximately 3 min per slice.

All native T~1~-weighted images and T~2~ maps included in analysis were acquired in vivo. To assess temporal changes in the T~1~-derived lesions and T~2~-derived edema, CMR-based volume measurements were normalized to those from the initial imaging time point post-ablation. We report all post-ablation times with respect to the start of ablation, as lesion formation commences at this point. Lesion volume temporal evolution was evaluated using a linear mixed model (LMM) to account for clustering by animal and baseline differences (MATLAB Statistics Toolbox). The ratio of T~2~-derived edema and T~1~-derived lesion volumes was calculated to provide a direct comparison of these volumes across individual ablations at different time intervals, assessed using analysis of variance (ANOVA). T~2~ evolution was assessed in three key ROIs: healthy tissue; T~1~-derived lesions; and edematous regions (the largest edematous ROIs for each ablation, to examine changes in a consistent tissue region). LV wall thickness and lesion transmurality (lesion depth divided by wall thickness) were also compared at different time points.

Lesion diameters measured manually from the final in vivo IR-SSFP images acquired were compared to those from morphologically matched gross tissue slices (the gold standard for lesion formation). Lesions in MCLE images were segmented manually to compare lesion volumes derived from native-contrast and contrast-enhanced images. Both comparisons were performed using Bland-Altman analysis. All measurements are reported as the mean ± SD unless indicated otherwise, and *p* \< 0.05 was considered statistically significant.

Results {#Sec8}
=======

RF lesion temporal evolution {#Sec9}
----------------------------

The native T~1~-derived lesion and T~2~-derived edema were clearly visualized and reflected the characteristic teardrop shape of RF lesions observed in corresponding contrast-enhanced images, gross pathology, and histopathology (Fig. [2](#Fig2){ref-type="fig"}). Elevated T~2~ indicating edema surrounding the ablation site was evident in the first T~2~ maps acquired as early as 3 min after the start of ablation. T~2~ maps were analyzed across 13 ablations visualized in 1--3 adjacent imaging slices in 11 animals. Each T~2~-derived edematous region was visualized at 5 ± 3 (median 4) time points following ablation. These regions tended to initially appear more focal and localized to the lesion border, assuming a more diffuse appearance by later time points (Fig. [3](#Fig3){ref-type="fig"}).Fig. 2RF lesion visualization using native-contrast and contrast-enhanced CMR, gross pathology, and histopathology. **a** T~2~ map (74 min post-ablation) demonstrating T~2~ elevation associated with edema near the ablation site (arrow). **b** IR-SSFP (TI = 730 ms, 81 min post-ablation) demonstrating the hyper-enhanced lesion. **c** MCLE (TI = 805 ms, 106 min post-ablation, approximately 6 min post-Gd injection), demonstrating the dark region of microvascular obstruction, at the lesion centre, with bright surrounding tissue. **d** Gross pathology (with a second lesion slightly out of plane; scale bar = 1 cm). Magnified (**e**) H&E and (**f**) MT stained lesion tissue sectionsFig. 3T~2~-derived edema development with time post-ablation. Anterior LV wall RF lesion visualization in T~2~ maps acquired 11--129 min post-ablation. Black lines delineate segmented T~2~-derived edematous regions

The volume of T~2~-derived edema was 0.77 ± 0.55 mL (*n* = 13) at the baseline measurements from the earliest T~2~ maps acquired (median 10 min post-ablation). The development of edema is shown in Fig. [4](#Fig4){ref-type="fig"}, illustrating the overall increase in volume compared to baseline. Normalized edema volume increased significantly beyond baseline (LMM slope = 0.003 ± 0.001, mean ± SE, *p* = 0.009, intercept = 1.20 ± 0.01, *p* \< 0.0001). Using this model, T~2~-derived edema expanded to an estimated 1.7 ± 0.2 (mean ± SE) times the baseline volume by 180 min post-ablation. Although the overall trend indicated increasing volume, in 6/13 of T~2~-derived edematous regions the volume increased then later dropped (while still remaining 1.3 ± 0.6 times larger than baseline). The maximum T~2~-derived edema volume estimated across all lesions was 1.5 ± 1.0 mL. T~2~-derived edema did not consistently develop concentrically around the catheter contact point.Fig. 4Evolution in volumes of acute T~2~-derived edema post-ablation. **a** Anterior wall RF lesion visualized in T~2~ maps with T~2~-derived edema delineated (black lines; scale bars = 1 cm). **b** Cumulative volume of T~2~-derived edema normalized to baseline (the first image acquisition), with time after ablation. Interpolated data from 13 lesions were used to calculate mean and SE curves. All acquired data were used; the mean curve is shown only out to 172 min due to insufficient data beyond this point to create error bars

The TIs used for T~1~-derived lesion visualization using IR-SSFP were TI = 831 ± 150 ms. These lesion volumes were measured in 9 lesions in 9 animals, each visualized in 1--3 adjacent imaging slices at 5 ± 2 (median 4) time points post-ablation (summarized in Fig. [5](#Fig5){ref-type="fig"}). The mean volume from the baseline IR-SSFP images was 0.48 ± 0.23 mL (*n* = 9, median 20 min post-ablation). Cumulatively, a small trend towards decreasing normalized T~1~-derived lesion volume was detected up to 180 min post-ablation (LMM slope = − 0.0006 ± 0.0003, mean ± SE, *p* = 0.09, intercept = 1.01 ± 0.04, *p* \< 0.0001). Using this model, T~1~-derived lesion volumes reached an estimated 0.9 ± 0.1 (mean ± SE) times the baseline volume by 180 min post-ablation.Fig. 5Monitoring volumes of acute T~1~-derived lesions post-ablation. **a** Anterior wall RF lesion visualized using IR-SSFP with lesion delineated (red lines; scale bars = 1 cm). **b** Cumulative volume of the T~1~-derived lesions normalized to baseline (the earliest imaging time) with time after ablation. Interpolated data across 9 lesions were used to calculate mean and SE curves. All acquired data were used; the mean curve is shown only out to 184 min due to insufficient data beyond this point to create error bars

The T~2~-derived edema consistently encompassed T~1~-derived lesions at individual ablation sites (Fig. [6](#Fig6){ref-type="fig"}), further supporting the distinctive tissue regions identified with each imaging contrast. The edema-lesion volume ratio was initially 2.1 ± 1.0 (0--25 min post-ablation, 95% CI \[1.1, 3.0\]). This ratio increased to 3.6 ± 1.1 (60--80 min; 95% CI \[2.5, 4.8\]), and reached 4.4 ± 3.2 (95% CI \[1.1, 7.8\]) by the final time interval at 80--185 min post-ablation. Although differences between intervals were not statistically significant (*p* = 0.2, ANOVA), volume ratios were greater than 1 within each interval (*p* \< 0.05). The RF energy delivered did not correlate to the maximum measured T~1~-derived lesion or T~2~-derived edema volumes (*r* = − 0.2, 0.4; *p* = 0.7, 0.2, Spearman's rho test); however, true energy deposition likely varied with catheter contact force, orientation, and blood flow.Fig. 6Ratio of T~2~-derived edema volumes to T~1~-derived lesion volumes post-ablation. T~2~-derived edema volume compared to T~1~-derived lesion volume at corresponding time points within 3 time intervals: initial lesion measurements within 0--25 min post-ablation; lesion progression within 60--80 min; and towards the end of CMR studies within 80--185 min post-ablation

T~2~ was evaluated in 3 critical regions: the T~1~-derived lesion; maximum T~2~-derived edematous region; and healthy tissue (Fig. [7](#Fig7){ref-type="fig"}). T~2~ within the T~1~-derived lesion ROIs increased between 0 and 25 min (53 ± 10 ms) and 60--80 min post-ablation (55 ± 8 ms, *p* = 0.04), then returned to the initial T~2~ at 80--185 min (53 ± 7 ms, *p* = 0.08). T~2~ within the largest edematous regions was significantly higher than in the T~1~-derived lesions overall (*p* \< 0.001) and initially increased between 0 and 25 min (53 ± 15 ms) and 60--80 min post-ablation (58 ± 13 ms, *p* \< 0.001), then decreased at 80--185 min, still remaining significantly higher than baseline (56 ± 15 ms, *p* \< 0.001). T~2~ within both T~1~-derived lesions and largest edematous regions were significantly higher than in healthy tissue (39 ± 5 ms, *p* \< 0.001), and T~2~ in healthy tissue did not change significantly during corresponding time intervals (*p* = 0.2, ANOVA).Fig. 7Longitudinal T~2~ post-ablation in healthy tissue, T~2~-derived edematous regions, and T~1~-derived lesions. Time course of: T~2~ in healthy tissue (*n* = 13 volumes); T~2~-derived edematous regions (*n* = 13); and T~1~-derived lesions (*n* = 8). Traces are shown for the time course corresponding to that shown in Figs. [4](#Fig4){ref-type="fig"} and [5](#Fig5){ref-type="fig"}

The lesions were not generally transmural. T~2~-derived edema was 76 ± 18% transmural at baseline (15 ± 10 min post-ablation), reaching 79 ± 22% at final measurement (120 ± 67 min; *p* = 0.9). Similarly, transmurality of the T~1~-derived lesion did not change significantly from initial measurements of 52 ± 10% (21 ± 7 min post-ablation) to 50 ± 11% (162 ± 63 min; *p* = 0.3). LV wall swelling occurred at the ablation sites between pre-ablation (8 ± 2 mm) and baseline post-ablation measurements (11 ± 2 mm; *p* = 0.01), but further swelling through to the end of the studies was not substantial (12 ± 2 mm; *p* = 0.2). Wall thickness at remote sites remained consistent with pre-ablation measurements of 9 ± 2 mm, reaching 8 ± 2 mm initially post-ablation (*p* = 0.5) and 9 ± 2 mm (*p* = 0.9) at the end of the studies.

Final pattern of ablation {#Sec10}
-------------------------

MCLE validation imaging reflected the lesion geometry consistently observed in corresponding intra-procedural images (Fig. [2](#Fig2){ref-type="fig"}). The MCLE-derived lesion volumes were 0.75 ± 0.39 mL (*n* = 9), significantly larger than those measured in the corresponding final IR-SSFP acquisitions (*n* = 6; bias = 0.41 ± 0.31 mL, *p* = 0.03; 95% limits of agreement \[0.08, 0.74\]), and smaller than the corresponding final T~2~-derived edema volumes (*n* = 9; bias = 0.45 ± 0.79 mL, *p* = 0.2; 95% limits of agreement \[− 0.16, 1.1\]).

Lesion diameters observed in gross pathology slices and in the final IR-SSFP acquisition were well correlated (*n* = 9 lesions, Pearson's *r* = 0.87, slope = 0.9, *p* = 0.003), with a relatively small bias of 0.4 ± 1.0 mm (gross lesion diameter = 9.7 ± 2.0 mm, T~1~-derived lesion diameter = 10.1 ± 2.0 mm; 95% limits of agreement \[− 0.41, 1.2\]).

Histological characteristics of RF lesions {#Sec11}
------------------------------------------

RF lesions exhibited the characteristic pale pink core of thermal injury bordered by a dark rim in gross pathology (Fig. [2d](#Fig2){ref-type="fig"}), also reflected in histological sections (Fig. [2e](#Fig2){ref-type="fig"}-[f](#Fig2){ref-type="fig"}). Morphologic changes were emphasized using H&E (cytoplasm and extracellular matrix are stained pink, nuclei stained purple), and viability emphasized using MT (ischemic or necrotic tissue is stained purple, healthy viable myocytes red, and connective tissue blue).

The lesion core in H&E sections (Fig. [8a](#Fig8){ref-type="fig"}-[b](#Fig8){ref-type="fig"}) exhibited disrupted cellular architecture consistent with thermal coagulation \[[@CR28], [@CR29]\] and the purple colour of the corresponding MT section (Fig. [8f](#Fig8){ref-type="fig"}) suggested non-viability of this tissue. The surrounding rim (Fig. [8c](#Fig8){ref-type="fig"}) was also distinguished by altered cellular architecture, and contained extravasated red blood cells, evidence of hemorrhage. The purple-to-red colour gradient outward from the lesion rim (Fig. [8g](#Fig8){ref-type="fig"}) suggested an increasing proportion of viable myocytes with distance from the catheter contact point. Interstitial space was increased conspicuously throughout the lesion (Fig. [8b](#Fig8){ref-type="fig"}-[c](#Fig8){ref-type="fig"}) and extending beyond the lesion rim (compared to healthy tissue; Fig. [8d](#Fig8){ref-type="fig"}), consistent with observations of broad T~2~-derived edematous regions.Fig. 8Histological sections of ablated tissue. Full extent of the lesion is shown in (**a**) stained with H&E, which highlights morphologic changes. **e** Full extent of the lesion stained with MT. **b** Magnified H&E section from the lesion core, showing cells exhibiting redistribution of extra/intracellular fluids due to thermal coagulation (resulting in the darker appearance of tissue). **c** Magnified H&E section from the lesion rim. Wide interstitium (black arrowheads) is evident relative to (**d**), healthy remote tissue. **f**-**h** Magnified MT sections from tissue zones corresponding to the H&E panels above. In the lesion rim, panels (**c**) and (**g**), extravasated red blood cells (RBCs) and vessels containing thrombosed RBCs (white arrowhead), blocking blood flow, are evident. All scale bars = 1 mm

Discussion {#Sec12}
==========

Main findings {#Sec13}
-------------

Native-contrast CMR was used to construct a comprehensive description of RF lesion composition and temporal evolution in the LV. Intra-procedural T~1~- and T~2~-based imaging performed concurrently each reflect a distinctive region of tissue injury, evolving separately throughout the time period of an intervention. Acute T~1~-derived lesions (thought to represent the permanent lesion) remained at a relatively stable size whereas the broader T~2~-derived edema (likely transient injury) was dynamic, tended to expand over time, and consistently extended beyond T~1~-derived lesions.

Lesion visualization immediately post-ablation {#Sec14}
----------------------------------------------

By performing ablation under CMR guidance, intra-procedural visualization of the T~1~-derived lesions and T~2~-derived edema was achieved within minutes after ablation. T~1~ contrast after ablation is believed to originate from oxidation of ferrous (Fe^2+^) to ferric (Fe^3+^) iron associated with the transformation of hemoglobin to paramagnetic methemoglobin occurring at 55--65 °C \[[@CR7], [@CR30]\], and a recent study using real-time CMR thermometry during ablation showed that native T~1~ contrast reflects tissue which received a lethal thermal dose \[[@CR17]\].

The acute lesions appeared desiccated in the central core, from T~2~ maps showing a zone of shorter T~2~ than the surrounding tissue (Fig. [3](#Fig3){ref-type="fig"}). Ablation-induced injury may be explained by comparison to general descriptions of thermal injury and edema pathogenesis \[[@CR28], [@CR31]\]. A sub-lethal thermal dose in tissue surrounding the lesion core is likely the cause of edema formation there. Microvessel permeability may be initially increased around the lesion core due to the release of biochemical factors such as histamine into injured tissue, leading to accumulation of fluid (edema).

Acute lesion evolution minutes to hours post-ablation {#Sec15}
-----------------------------------------------------

Native-contrast CMR facilitated repeated measurement of both the T~1~-derived lesion and the T~2~-derived edema to assess their acute evolution throughout the interventional procedure. The evolution of native CMR contrast is of particular importance since lesion measurements can be repeated easily at different points in the procedure, while gadolinium-enhanced studies are limited to a single injection of contrast.

The acute T~1~-derived lesions appeared largely stable in volume, corroborating and extending existing studies that showed T~1~-derived lesions visualized acutely had a consistent extent which corresponded well to lesions visualized hours, weeks, and months post-ablation \[[@CR5], [@CR6], [@CR13], [@CR17]\]. By combining the results from this study with the existing data on T~1~-derived lesions, we suggest that the spatial extent of these lesions is established immediately after ablation, with damaged tissue later replaced by fibrotic scar. The subtle trend seen in this study toward decreasing T~1~-derived lesion size with time could be explained by passive edema diffusion toward the initially desiccated centre of the lesion, driven by reduced interstitial pressure there. Interstitial pressure changes in burned tissue are generally driven by the release of particles which drive osmotic pressure, drawing fluid into the interstitium \[[@CR31]\]. Increasing water content would elevate local T~1~, opposing the reduction of T~1~ due to iron transformation.

The interstitium in thermally injured tissue tends to become more compliant, perpetuating fluid accumulation, with damage to matrix molecules such as collagen and hyaluronic acid. Increased permeability of injured microvessels leads to continued fluid leakage into the interstitial space \[[@CR31]\]. Microvascular injury has previously been detected up to 6 mm beyond the pathological RF lesion core \[[@CR29], [@CR32]\], and the resulting ischemic effects likely contributed to the continuing increase in T~2~-derived edematous volumes and the increasing T~2~ within these regions up to approximately 60 min post-ablation (Fig. [7](#Fig7){ref-type="fig"}). The edema likely reached a stable extent once opposing interstitial and vascular pressures equalized, then later a more homogeneous fluid distribution with passive diffusion, consistent with the decreasing then stable T~2~ after the initial peak seen in edematous tissue towards the end of the CMR studies.

Non-concentric edema development of the T~2~-derived edema, and stable transmurality, could reflect preferential fluid spread occurring along cleavage planes between myocardial sheets, in line with LV muscle fibres that primarily run circumferentially. Beyond 120 min post-ablation, edematous regions appeared to have more diffuse borders (e.g., Fig. [3](#Fig3){ref-type="fig"}). Variable volume measurements at later time points could result from cases in which T~2~ elevation at the ablation site dropped below the 3 SD threshold; intensity-based segmentation is less robust to this diffuse pattern. Despite volume variability, the T~2~-derived edema volumes were still larger than immediate post-ablation dimensions (Fig. [4](#Fig4){ref-type="fig"}) and the corresponding T~1~-derived lesion volumes (Fig. [6](#Fig6){ref-type="fig"}).

Prior studies using T~2~-weighted CMR showed little change in edematous area beyond 3 min post-ablation \[[@CR16]\] and that the maximum lesion SI occurred at approximately 12 min post-ablation in the right ventricle (RV) \[[@CR4]\]. In the current study, elevated T~2~ in the maximum T~2~-derived edema ROIs reached a maximum at approximately 60 min post-ablation, possibly arising from a greater capacity for edema development in the LV (compared to thin-walled RV and atria), or the approach used to delineate the edema.

Study limitations & future work {#Sec16}
-------------------------------

The earliest T~2~ map acquisition in this study was 3 min after the start of RF energy delivery, and delays typically included catheter withdrawal and waiting for any ablation-induced arrhythmia to settle. T~1~-weighted image acquisition was performed at 13 min at the earliest; therefore any earlier changes among T~1~-derived lesions were missed. Nevertheless, these lesions appeared consistently smaller than the T~2~-derived edema, and were stable or shrinking instead of expanding for time points beyond 13 min post-ablation.

The 2D imaging sequences used in this study were appropriate to maintain relatively short scan times for concurrent imaging of the T~1~-derived lesion and T~2~-derived edema. We anticipate the use of 3D MCLE, a novel sequence using compressed sensing to acquire images of isotropic resolution in a single breath-hold developed for infarct characterization, in future procedures for rapid lesion assessment \[[@CR33]\]. Moving towards a future clinical workflow, high-resolution imaging would likely be necessary for pre-ablation targeting\--the importance of fine detail to describe complex re-entry circuits is well established in both interventional EP and imaging communities \[[@CR34], [@CR35]\]\--as well as benefiting lesion assessment, as seen recently \[[@CR13]\].

The pro-arrhythmic potential of tissue containing mixed viable and non-viable myocytes and potentially microvascular injury near the periphery of RF lesions was not investigated. However, prior work showed chronic lesions resembling well-circumscribed scar \[[@CR6]\], a pattern associated with lower arrhythmogenic potential than heterogeneous scar. The potential for pro-arrhythmia is likely greater in healthy tissue, as was the case in the healthy swine model used for this study. Practically, in the presence of infarcted tissue (as is typical for VT in structural heart disease), lesion pro-arrhythmia may have a small effect since areas ablated are likely to be already ischemic and surrounded by chronic fibrotic tissue. Investigating the properties of ablations on or adjacent to infarcted tissue would build on promising recent results \[[@CR13]\] and is an important direction for future studies. In ongoing CMR-based lesion assessment studies, we are also investigating the effect of ablation on the functional properties of local myocardial tissue \[[@CR36]\], extending previous studies of infarcted tissue \[[@CR37]\].

CMR-based intra-procedural lesion assessment {#Sec17}
--------------------------------------------

Native-contrast CMR imaging reflects ablation-induced tissue changes and facilitates consistent lesion assessment throughout MR-guided ablation. Considering the complexity of the arrhythmogenic substrate, lesion assessment should be repeatable when convenient for the interventionalist, supporting an iterative treatment approach.

Patients undergoing ablation for structural heart disease often exhibit multiple arrhythmia morphologies, suggestive of multiple re-entry circuits. CMR-based lesion assessment could be performed after delivering several ablations towards blocking a target re-entry circuit. Intermittent imaging exams and analysis would require 10--20 min to perform using the techniques employed in the current study (with segmentation not fully optimized for speed).

One proposed workflow for future clinical cases could involve identifying re-entry circuits in prior CMR-derived maps of scar and EP mapping, then delivering several ablations at a re-entry circuit while relying on EP data. T~1~-weighted CMR could be used to visualize a series of lesions created at the re-entry circuit. We suggest that ablation while incorporating this feedback should aim to produce lesions which appear continuous using T~1~-weighted imaging. Based on these T~1~-weighted images, remaining gaps identified at the re-entry circuit would clearly indicate that further ablation is needed, potentially constituting an additional procedural endpoint. T~2~ mapping could be used to interpret possibly discordant EP measures of procedural success, but should not be used alone for lesion assessment as the T~2~-derived edema likely reflects transient injury not contributing to long-term procedural success.

RF lesions could be visualized with the catheter held in place if lesions extend beyond the minimal artifact at the catheter tip, and others have proposed imaging and hardware based solutions for interventions \[[@CR38], [@CR39]\]. Catheter withdrawal before imaging (as in this study) may introduce challenges by causing the interventionalist to lose the catheter's position at the ablation site such that it would need to be directed back precisely for further ablations.

Conscious patients under light sedation may be able to perform breath-holds during intra-procedural CMR imaging, but for those unable, existing respiratory-navigated or real-time sequences could be adapted for lesion imaging \[[@CR40]\]. Rapid intra-procedural registration of lesion images to prior scar maps would be needed to provide useful feedback to the interventionalist.

Finally, contrast-enhanced imaging should be reserved to confirm the pattern of ablation at the true completion of the procedure. An alternative sequence recently proposed visualizes both scar and RF lesions with native T~1~ contrast \[[@CR13]\]. For either approach, high-resolution coverage of an extended region of the heart, after ablating multiple re-entry circuits, would require a respiratory-navigated acquisition of about 10--20 min. The timing of this acquisition after contrast-agent injection should also be chosen carefully given known contrast agent kinetics.

Clinical implications {#Sec18}
---------------------

Comprehensive understanding of acute lesion composition and evolution could be applied to both CMR-guided and non-CMR-guided ablation cases. In general, operators should be cognizant of the dynamic nature of edema, which could cause the acute appearance of a successful ablation procedure. The evolving, broad extent of T~2~-derived edema may mask the smaller T~1~-derived lesions (specifically indicated by the ratio of these volumes) which are thought to reflect true procedural success. T~1~-based imaging could potentially constitute an additional procedural endpoint. CMR-based lesion assessment could make a critical difference in scenarios where re-entry circuits appear to be blocked, for instance with more transmural T~2~-derived edema injuring deep epicardial re-entry circuits not reached by the T~1~-derived lesion. These findings may be used to help explain mechanisms of arrhythmia recurrence after acutely successful appearing procedures.

Conclusions {#Sec19}
===========

Native T~1~- and T~2~-based imaging performed concurrently throughout CMR-guided ablations demonstrated that acute T~1~-derived lesions remained at a stable size while the T~2~-derived edema was dynamic, expanded over time, and consistently extended beyond the T~1~-derived lesion. T~2~ quantification provides an unambiguous measure of edema development and severity near ablation sites. Lesion evolution is important for comparing CMR lesion visualization and EP-based endpoints, data which may be acquired at disparate time points. Integrated information on the T~1~-derived lesion and T~2~-derived edema provides a description of acute lesion composition that could be most useful during ablation procedures.
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